Utilizing Replit to increase product experimentation rates by an order of magnitude.

Achieved cash-flow positive status and high subscription growth, signaling a likely final private round before an IPO.

Mentioned as a comparable product in the growing health-tracking and biohacking space. Unlike Eight Sleep, it is considered a passive tracker.